Ballicules.com

Ticlopidine

TICLID

Pronunciation: tye-KLOE-pi-deen

Ticlopidine ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Ticlopidine ballicule
Ticlopidine TICLID mascot mnemonic cartoon
Visual mnemonic: Ticlopidine mascot
“Tic Tic lid opened”

What it isIrreversible P2Y12 antagonist; the first thienopyridine.

Why this oneIt established P2Y12 blockade as an antiplatelet strategy, which clopidogrel then made practical.

What limits itNeutropenia and thrombotic thrombocytopenic purpura required frequent counts. Obsolete.

Ticlopidine molecular structure (skeletal formula)
Molecular structure: Ticlopidine

FDA-approved for

FDA label

BOXED WARNING Life-threatening hematologic reactions: neutropenia/agranulocytosis, thrombotic thrombocytopenic purpura (TTP), and aplastic anemia; monitor hematologically and clinically during first 3 months; discontinue immediately if evidence occurs.
FDA dosingPopulationStartTargetMax
Stroke (thrombotic) risk reductionAdults250 mg BID250 mg BID
Coronary artery stenting (adjunct with aspirin)Adults250 mg BID250 mg BID up to 30 days

Renal Undefined

Hepatic Contraindicated in severe hepatic impairment

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No adequate human studies; use in pregnancy only if clearly needed (former category B)

Lactation Undefined

⚠ BOXED WARNINGS

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryB

Defining liabilityLife-threatening blood dyscrasias requiring early fortnightly monitoring

Open Ticlopidine in the interactive console ↗

Memory aids: interaction avatars

Ticlopidine CYP2B6 inhibitor avatar mnemonic
CYP2B6 inhibitor (moderate)

Open Ticlopidine in the interactive console ↗